To elucidate the effect of RUNX1 expression on survival of NSCLC patient, we analyzed the expression of RUNX1 using immunohistochemistry of formalin-fixed paraffin-embedded tumor tissues from 409 NSCLCs. The gene discussed is RUNX1; the disease is neoplasm.